GL1X · GenesisL1 explorer

Research workbench

Heparin-binding domain from vascular endothelial growth factor, NMR, 20 structures

Analyse Heparin-binding domain from vascular endothelial growth factor, NMR, 20… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1VGH
Type
protein
Length
55 residues
Chains
1
Method
solution nmr
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Vascular endothelial growth factor-165
UniProt
P15692

Structure

solution nmr · 1 distinct chain · 11% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AVascular endothelial growth factor-165protein5511% helix, 22% strandP15692

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 1VGH · Heparin-binding domain from vascular endothelial growth factor, NMR, 20 structures · the same entry in another collection · chain A against A, TM-score 1.00
  • P15692 · AlphaFold monomer V2.0 prediction for vascular endothelial growth factor a (P15692) · a predicted model of the same protein · chain A against A, TM-score 0.72

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.